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Abstract—The clonal selection principle is used to explain the
basic features of an adaptive immune response to a antigenic
stimulus. It established the idea that only those cells that
recognize the antigens are selected to proliferate and differentiate.
This paper explains a computational implementation of the
clonal selection principle that explicitly takes into account the
affinity maturation of the immune response. The clonal selection
algorithm by incorporating receptor editing method, RECSA, has
been proposed by Gao. This paper tries to classify the medical
database of Coronary Heart Disease databases and reports the
computational results for 4 kinds of training datasets.
I. INTRODUCTION
In a few decades, the area of artificial immune system (AIS)
has been an ever-increasing interested in not only theoret-
ical works but applications in pattern recognition, network
security, and optimizations[1],[2],[3],[4],[5],[6],[7]. AIS uses
ideas gleaned from immunology in order to develop adaptive
systems capable of performing a wide range of tasks in various
research areas. Especially, Gao focuses the Clonal Selection
Algorithm(CSA) which is known to one of the famous immune
algorithms and proposed the effective method for solving
Traveling Salesman Problem(TSP)[8] which is known to be
NP-complete.
The biological basis of the Clonal Selection Theory was
proposed by Burent[13],[14] in 1959. The theory interprets
the response of lymphocytes in the face of antigenic stimulus.
Only the immune cells with high affinity are selected to
proliferate, while those low affinity cells must be efficiently
deleted or become anergic. The hypermutation is allowed
to improve the affinity of the selected cells to the selective
antigens. Receptor Editing as a mechanism of immune cell
tolerance is reported[9],[10],[11].
Gao indicated the complementary roles of somatic hyper-
mutation (HM) and receptor editing (RE) and presented a
novel clonal selection algorithm called RECSA model by
incorporating the Receptor Editing method[8]. In [8], they
discussed the relationships between HM and RE through
utilizing them to solve the TSPs. Because a valid tour in TSP
is represented by a permutation of N cities, the number of
states to feasible tours is (N−1)!. [1] solves the problems for
finding an optimal set in the search space consisted of the set
of (N − 1)! valid tours in TSPs.
A medical database named Coronary Heart Disease
Database (CHD DB) has been prepared in the data mining
contest. The database makes it possible to assess the effective-
ness of data mining method in medical data. The CHD DB is
based on actual measurements of the Framingham Heart Study
- one of the most famous prospective studies of cardiovascular
disease. It includes more than 10,000 records related to the
development of coronary heart disease (CHD). The datasets
have been proved enough valid by statistical analyses[12].
This paper challenges to classify the CHD DB by using
RECSA model. The classification of medical database differs
from the TSP, because medical information such as results
of biochemical tests and chief complaint is often ambiguous.
Therefore, we cannot clearly distinguish the difference be-
tween normal and pathological values. Biochemical test values
cannot be precisely evaluated by using crisp sets. In this
paper, we consider that the database has some relation between
inputs and output signals. That is, an output is summed up
all the inputs modified by their respective weights and is
compared with the corresponding teach signal. We report the
computational classification results of the databases.
The remainder of this paper is organized as follows. In the
next serction, the clonal selection theory will be explained
briefly. Section 3 will explain RECSA model proposed by [8].
The CHD DB will be described in Section 4. Experimental
results for classification of the CHD DB will be reported in
Section 5. In Section 6, we give some discussions to conclude
this paper.
II. THE CLONAL SELECTION THEORY
Burnet proposed the clonal selection theory in order to
explain the essential features of adaptive immune response
[13][14]. The basic idea of this theory interprets the response
of lymphocytes in the face of an antigenic stimulus. Fig.1
shows the overview of clonal selection principal.
Any molecule that can be recognized by the adaptive
immune system is known as antigens (Ags). Some subpopula-
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tions of its bone-marrow-derived cells responds by producing
antibody (Ab). Abs are molecules attached primarily to the
surface of B cells. The aim of B cell is to recognize and bind
to Ags. Each B cell (B lymphocytes) secretes a single type of
Ab. By binding to these Abs and with a second signal from
T-helper cell, the Ag stimulates the B cell to proliferate and
mature into terminal Ab secreting cells called plasma cells.
Proliferation of the B cell is a mitotic process whereby the
cells divide themselves, creating a set of clones identical to
the parent cell. The proliferation rate is directly proportional
to the affinity level. That is, the higher affinity level of B
cells, the more of them will be readily selected for cloning
and cloned in larger numbers.
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Fig. 1. An overview of the clonal selection principle
In addition to proliferating and differentiating into plasma
cells, B cells can differentiate into long lived B memory cells.
Memory cells circulate through the blood, lymph, and tissues.
By exposing to a second antigenic stimulus, they commence
to differentiate into plasma cells capable of producing high
affinity Abs, which are preselected for the specific Ag that
stimulated the primary response.
Gao has been proposed the clonal selection method by in-
corporating receptor editing which can diversify the repertoire
of antigen activated B cells during asexual reproduction[8].
The proposed method has two mechanisms of somatic hyper-
mutation and receptor editing [15][16][17].
First, the basic idea of somatic hypermutation is explained.
A rapid accumulation of mutations is necessary for a fast
maturation of immune response. A large proportion of the
cloned population becomes dysfunctional or develops into
harmful anti-self cells after mutation. However, an effective
change enables the offspring cell to bind better with antigen,
then affinity is improved. When a mutated cloned cell with
higher affinity is found, it will be activated to undergo prolif-
eration. The mutation in the cloned cells happens with inverse
proportional to the antigen affinity. This process of constant
selection and mutation of only the B cells with antibodies is
affinity maturation. The immune system is capable of evolving
antibodies to recognize and bind with not only known antigens
but unknown ones by affinity maturation. However, those cells
with low affinity may be further mutated.
Second, receptor editing, the main role in shaping the
lymphocyte repertoire, is explained. Both B cell and T cell that
carry antigen receptors are able to change specificity through
subsequent receptor gene rearrangement. The antigen molecule
is composed of two chains, each resulting from the somatic
rearrangement of various genetic segments as shown in Fig.
2 and Fig. 3. The B cell expresses at their surface a receptor
allowing them to specifically recognize antigens. These figures
show the rearrangement at the stage of the pro-B cells. In
the primal rearrangement as shown in Fig.2, the heavy chain
locus is rearranged to produce a VDJ segment. It encodes
numerous V(variable), D(Density), J(Junction) segment. When
one D segment and one J segment join together, a V segment is
then joined to the assembled DJ. This pattern forms a unique
combination of VDJ. In the secondary rearrangement as shown
in Fig.3, the process governing B cell tolerance is the light
chain. In case locus lack D region, only V and J segment will
be assembled. After an initial VJ rearrangement, upstream V
segment can be further rearranged to downstream J segment,
deleting or displacing the previously rearranged VJ segment.
Furthermore, numerous V regions are in reverse orientation on
chromosome, these V are rearranged by inversion rather than
by deletion of the intervening sequences.
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Fig. 2. The arrangement of VDJ (a)heavy chain
In addition to somatic hypermutation and receptor editing, it
should be note that some of stimulated lymphocytes is replaced
per cell generation by newcomer cells from the bone marrow.
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Fig. 3. The arrangement of VDJ (b)light chain
III. RECSA MODEL[8]
The shape-space model aims at quantitatively describing the
interactions among Ags and Abs (Ag-Ab) [18][19]. The set of
features that characterize a molecule is called its generalized
shape. The Ag-Ab codification determines their spatial repre-
sentation and a distance measure is used to calculate the degree
of interaction between these molecules. Mathematically, the
generalized shape of a molecule (m) can be represented by
a set of L attributes directly associated with coordinate axes.
These axes are represented by m = 〈mL, · · · ,m2,m1〉 which
can be regarded as a point in an L-dimensional real-valued
shape space S,m ∈ SL ⊂ ℜL. So we can express the immune
cell’s receptor gene sequence as R = (r1, r2, · · · , rL).
The Gao’s model[8] as shown in Fig. 4 can be described as
follows.
Step1) Create an initial pool of m antibodies as candidate
solutions(Ab1 ,Ab2 , · · · ,Abm).
Step2) Compute the affinity of all antibodies:
(D(Ab1 ), D(Ab2 ), · · · , D(Abm)). D() means
the function to compute the affinity.
Step3) Select n best individuals based on their affinities
from the m original antibodies. These antibodies will
be referred to as the elites.
Step4) Sort the n selected elites in n separate and distinct
pools in ascending order. They will be referred to as
the elite pools.
Step5) Clone the elites in the pool with a rate proportional to
its fitness. The amount of clone generated for these
antibodies is given by Eq.(1).
Pi = round(
n− i
n
×Q) (1)
i is the ordinal number of the elite pools, Q
is a multiplying factor for determining the scope
of the clone and round() is the operator that
rounds towards the closest integer. Then, we
can obtain
∑
pi antibodies as ((Ab1 ,1 ,Ab1 ,2 , · · · ,
Ab1 ,p1 ), · · · , (Abn,1 ,Abn,2 , · · · ,Abn,pn )).
Step6) Subject the clones in each pools through either hyper-
mutation or receptor editing process. The mutation
rates, Phm for hypermutation and Pre for receptor
editing given by Eq.(2) and Eq.(3), are inversely
proportional to the fitness of the parent antibody,
Phm = a/D() (2)
Pre = (D() − a)/D() (3)
, where D() is the affinity of the current parent
antibody and a is an appropriate numerous value.
Step 7)Determine the fittest individual Bi in each elite pool
from amongst its mutated clones. The Bi is satisfied
with the following equation.
D(Bi) = max(D(Abi,1 , · · · ,Abi,pi )), i = 1, 2, · · · , n
(4)
Step 8)Update the parent antibodies in each elite pool with
the fittest individual of the clones and the probability
P (Abi ,→ Bi) is according to the roles: if D(Abi) <
D(Bi) then P = 1, if D(Abi) ≥ D(Bi) then P = 0,
otherwise exp(D(Bi)−D(Abi)
α
).
Step 9)Replace the worst c elite pools with new random
antibodies once every k generations to introduce
diversity and prevent the search from being trapped
in local optima.
Step10)Determine if the maximum number of generation
Gmax to evolve is reached. If it is satisfied with this
condition, it terminates and returns the best antibody.
Otherwise, go to Step 4).
IV. CORONARY HEART DISEASE DATABASE[12]
A. An overview of Framingham Heart Study
The Framingham Heart Study was the first prospective study
of cardiovascular disease. The study began in 1948 under
the direction of the National Heart Institute (now known as
the National Heart, Lung, and Blood Institute) in the United
States. Participants were randomly sampled from the town of
Framingham, Massachusetts. Examination of participants has
taken place every two years and the cohort has been followed
for morbidity and mortality over that time period.
Over the five decades, the Framingham Heart Study has
provided valuable insights into the epidemiology and patho-
physiology of CHD. The study identified constitutional and
environmental factors associated with the development of
CHD and established the concept of risk factors and their joint
effects.
B. Six-year follow-up experience
The following factors are known as a major risk factor for
CHD and used for estimating the individual risk of developing
CHD within a ten-year time period[20]: old age, smoking, high
blood pressure, high cholesterol, and diabetes mellitus. Most
of the factors were mentioned first in the reports on six-year
follow-up in the Framingham Heart Study[21],[22].
Fig.5 shows the six-year follow-up in the Framingham Heart
Study. The cohort consisted of 5,127 men and women aged 30
to 59 who were initially free of CHD. At the study inception in
1948, they received a physical examination, laboratory tests,
and a lifestyle interview. The cohort has been followed by
means of biennial examinations including a detailed medical
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Fig. 4. A flowchart of RECSA model
history, a physical examination, and laboratory tests. There
were 186 persons who developed CHD during the follow-up
period. The six-year incidence of CHD in the age group of 45
or older was 9.1% in men and 4.5% in women.
Random Sample
Men and Women
aged 30 to 59
in Framingham,
Massachusetts, USA
(n=5,127)
Initial
Examination
Biennial
Examination
Development of
Coronary Heart Disease
Baseline Data
National Origin
Education
Tobacco
Alcohol
Systolic Blood Pressure
Diastolic Blood Pressure
Cholesterol
Left Ventricular Hypertrophy
Fig. 5. Six-year follow-up in the Framingham Heart Study
C. Database Design
The CHD DB is designed to reproduce the original data of
the Framingham Heart Study. Requisite information is derived
from the reports on six-year follow-up in the Framingham
Heart Study [23],[24].
Table I shows the data items of the CHD DB. Each of the
datasets consists of ten data items: ID, development of CHD,
and eight items that were collected from the initial examination
(i.e. baseline data). The eight items; ORIGIN, EDUCATE, TO-
BACCO, ALCHOL, SBP, DBP, TC, and LVH, were examined
whether it was associated with the development of CHD over
six-year follow-up in the Framingham Heart Study. Using the
CHD DB, researchers will develop a prognostic system that
will discriminate between those who developed CHD (CHD
cases) and those who did not (Non-CHD cases) on the basis
of the eight data items as shown in Fig.6.
The CHD DB consists of four training datasets (Train A,
X, Y, and Z) and one testing dataset (Test) as shown in
Fig.7. We previously reported that the developed prognostic
system highly depended on the quality of training dataset [25].
The small proportion of cases to non-cases in the training
dataset might contribute to a poor learning about the cases,
and consequently, the developed prognostic system might have
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TABLE I
DATA ITEMS OF CORONARY HEART DISEASE DATABASE
Data Item Name Value
ID ID Sequential Value
Development of CHD CHD 0=No; 1= Yes
National Origin ORIGIN 0=Native-born; 1=Foreign-born
Education EDUCATE 0=Grade School; 1=High School, not graduate; 2=High School, graduate; 3=College
Tobacco TOBACCO 0=Never; 1=Stopped; 2=Cigars or Pipes; 3=Cigarettes(<20/day); 4=Cigarettes(≤20/day)
Alcohol ALCOHOL Continuous Value(oz/mo)
Systolic Blood Pressure SBP Continuous Value (mmHg)
Diastolic Blood Pressure DBP Continuous Value (mmHg)
Cholesterol TC Continuous Value (mg/dl)
Left Ventricular Hypertrophy LVH 0=None; 1=Definite or Possible
Developmentof
Coronary Heart Disease
Baseline Data
National Origin
Education
Tobacco
Alcohol
Systolic Blood Pressure
Diastolic Blood Pressure
Cholesterol
Left Ventricular Hypertrophy
Prognostic
System
Fig. 6. Prognostic System for the development of CHD
Train_A
and Test
(n=13,000)
Non-CHD
Cases
CHD
Cases
Train_X
(n=19,500)
Train_Y
(n=65,000)
Train_Z
(n=4,000)
Fig. 7. Training and test datasets
lack of ability to identify potential cases from the population
at risk. Therefore, the four training datasets are designed
to have different proportions of CHD cases to Non-CHD
cases. The number of combination of the eight data items is
expected to be about six and a half thousand: 2 (ORIGIN)
× 4 (EDUCATE) × 5 (TOBACCO) × 3 (ALCOHOL) × 3
(SBP) × 3 (DBP) × (TC) × 2 (LVH) = 6,480, where the
numerical data are counted as three. In the original data of
the Framingham Heart Study, the number of complete records
was about four thousand and the proportion of CHD cases to
Non-CHD cases in men aged 45 or older was about one to
nine (i.e. the six-year incidence of CHD was 9.1%). Therefore,
Train A, Train X, and Train Y include 6,500 CHD cases and
6,500 (× 1), 13,000 (× 2), and 585,000 (× 9) Non-CHD cases,
respectively, while Train Z approximates to the original data
both for the number of total records and the proportion of CHD
cases to Non-CHD cases. On the other hand, for the testing
dataset, we prepared 6,500 CHD cases and 6,500 Non-CHD
cases separately from the training datasets.
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Fig. 8. The immune system for classification of CHD
V. EXPERIMENTAL RESULTS
First, we describes the preliminary requirements for the
classification of CHD DB by using RECSA model. The
antibody consists of k paratopes that the part of the molecule
of an antibody that binds to an antigen. There are k = 8
input signals in each record as shown in Table I, except ID
and CHD. The antibody in the experimentation is assumed
that the paratope consists of the weight, Wk, for input signals
and threshold value, θ, for an output, then the search for the
optimal set of P (w1, w2, · · · , wk, θ) as shown in Fig.8 will be
iterated by mutation. The initial set of W and θ is given an
appropriate positive real number. In this work, W and θ were
random numerous values in the range [0, w] and (0, θ], where
w = 2.0, θ = 8.
In order to calculate the affinities, the agreement degree of
antibodies and training data in CHD DB is measured by using
Eq.(5).
f(x) =
{
1 if
∑k
i=1 wixi ≥ θ
0 if otherwise
(5)
If f(x) is equal to a teach signal of training record, the
antibody has a high affinity. The number of such antibodies
shows an overall affinities in the classification of CHD DB
by using RECSA model.
Some parameters in RECSA model were taking same values
described in [8]. That is, we use the parameters: Gmax = 500,
m = 150, n = 100, Q = 50, α = 100, k = 30, c = 10, and
Phm : Pre = 0.5 : 0.5.
We use Java programming language on Pentium 4 3.20GHz
with 1.50GB RAM. The version of Java is JDK1.6.0 07.The
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TABLE II
NUMBER OF CORRECT ANTIBODIES(10 RUNS)
Dataset Best Worst Mean Variance Time(sec)
Train A 9,001(69.24%) 8,955(68.95%) 8976.8(69.05% ) 361.8 588.17
Test 9,092(69.94%) 8,999(69.22%) 9042.3(69.56%) 866.4 -
Train X 13,905(71.31%) 13,472(69.0%) 13680.4(70.16%) 21914.24 855.60
Test 9,081(69.85%) 9,008(69.29%) 9041.3(69.55%) 458.0 -
Train Y 46,313(71.25%) 45,163(69.48%) 45948.0(70.69%) 198469.2 2691.23
Test 9,099(69.99%) 8,997(69.21%) 9058.8(69.68%) 1141.2 -
Train Z 3,037(75.93%) 2,803(70.08%) 8923.6(68.64%) 2598.64 186.10
Test 9,064 (69.72%) 8,839(67.99%) 8944.2(68.80%) 4682.8 -
simulation for each dataset runs in 10 times by using
Eclipse3.4. The experimentaion computed the best and worst
antibody and mean of correct ratio in population.
Table II shows the classification results of Training dataset
and Test dataset for 4 kinds of training datasets(Train A, X,
Y, and Z). The classification result by the adaptive learning
method using neural networks in [27] was 82.3% for the
test dataset of Train A. The classification capability of our
proposed method was not so good compared to that of [27].
However, there was no difference between the correct ratio for
Training dataset and Test dataset over 10 runs, although each
training dataset has different proportion rate of CHD cases to
Non-CHD cases as shown in Fig.7.
VI. CONCLUSIVE DISCUSSION
The clonal selection principle established the idea that only
those cells that recognize the antigens are selected to prolif-
erate and differentiate. The method by [8], RECSA, explicitly
takes into account the affinity maturation of the immune
response by incorporating receptor editing method. This paper
classified 4 kinds of Coronary Heart Disease Database. The
computational results show about 69% correct ratio of test
dataset. The RECSA model can classify the medical dataset,
where includes some ambiguous data. However, the correct ra-
tio is not higher than other classification methods[27], because
the CHD database has some knowledge structure in the group
of input terms as shown in Fig.8. Future works will focus the
lateral interactive clonal selection algorithm [26] to enable the
knowledge acquisition automatically.
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